Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation
The proposed hepatic metabolic pathway and altered gene expression by treatment with ezetimibe (white arrow) in a rat model of obesity and type 2 diabetes. Abbreviations: ACSL1: long-chain acyl-coenzyme A synthetase 1; CCTα: CTP:phosphpocholine cytidylyltransferase alpha; DGAT: diacylglycerol acyltransferase; ELOVL5: elongation of very long chain fatty acids protein 5; FADS2: fatty acid desaturase 2; FATP5: fatty acid transport protein 5; L-FABP: liver fatty acid-binding protein; LPCAT: lysophosphatidylcholine acyltransferase; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PEMT: phosphatidylethanolamine N-methyl-transferase; PLA2: phospholipase A2; PC-PLC: PC-specific phospholipase C.
Publication
Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation. (2024) Hyekyung Yang, et al. Front Pharmacol. 2024;15:1406493. Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Fads2 | FADS2 | ncbigene_symbol | FADS2 | 9415 |
| Homo sapiens | Primates | Fads2 | FADS2 | ncbigene_synonym | RAPSN | 5913 |
| Homo sapiens | Primates | L-Fabp | L-FABP | ncbigene_synonym | FABP1 | 2168 |
| Homo sapiens | Primates | Fatp5 | FATP5 | ncbigene_synonym | SLC27A5 | 10998 |
| Homo sapiens | Primates | ACSL1 | ACSL1 | ncbigene_symbol | ACSL1 | 2180 |
| Homo sapiens | Primates | DGAT | DGAT | ncbigene_synonym | DGAT1 | 8694 |
| Homo sapiens | Primates | LPCAT | LPCAT | ncbigene_synonym | LPCAT3 | 10162 |
| Homo sapiens | Primates | LPCAT | LPCAT | ncbigene_synonym | LPCAT1 | 79888 |
| Homo sapiens | Primates | LPCAT | LPCAT | ncbigene_synonym | MBOAT2 | 129642 |
| Homo sapiens | Primates | TG | TG | ncbigene_symbol | TG | 7038 |
| Homo sapiens | Primates | ATGL | ATGL | ncbigene_synonym | PNPLA2 | 57104 |
| Homo sapiens | Primates | PC | PC | ncbigene_symbol | PC | 5091 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G1B | 5319 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G2A | 5320 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G6 | 8398 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G3 | 50487 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G5 | 5322 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G7 | 7941 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G10 | 8399 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G12A | 81579 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G12B | 84647 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2C | 391013 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2D | 26279 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2E | 30814 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2F | 64600 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4A | 5321 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4C | 8605 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4D | 283748 |
| Homo sapiens | Primates | PEMT | PEMT | ncbigene_symbol | PEMT | 10400 |
| Homo sapiens | Primates | PEMT | PEMT | ncbigene_synonym | MUC1 | 4582 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| LCFA | LCFA | chebi:15904 | ||
| Ezetimibe | ezetimibe | (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one | chebi:49040 | |
| LCFA-CoA | LCFA-CoA | chebi:33184 | ||
| Diacylglycerol | Diacylglycerol | chebi:90071 | ||
| LCFA-CoA | LCFA-CoA | chebi:33184 | ||
| VLDL | VLDL | chebi:39027 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|